THE first trial of stem cell therapy
for arthritic knees is set to start
shortly in Great Britain.
The one year trial will see
patients treated with a mixture of
their own bone marrow stem cells,
mixed with their own carrtilage
cells, via an injection into their
knee at the site of damage or
wear, with results marked on how
effective the treatment is in
developing new quality cartilage.
It is hoped this study will
eventually provide an alternative to
knee replacement surgery.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jul 10
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.